Anika Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Anika Therapeutics, Inc. (ANIK) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$8.42 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-07-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-07-28
- Anika Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$8.30M.
- Anika Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$253.16K.
- Anika Therapeutics, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$1.50M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|
| 2017-06-30 | -$8.42M 10-Q · filed 2017-07-28 | |
| 2016-06-30 | -$4.62M 10-Q · filed 2017-07-28 | |
| 2014-12-31 | -$8.30M 10-K · filed 2015-03-13 | |
| 2013-12-31 | -$253.16K 10-K · filed 2015-03-13 | |
| 2012-12-31 | -$1.50M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |